A Good Choice To Have: Scrip’s Interview With Viking CEO Brian Lian

 
• By Joseph Haas

Still a clinical-stage company, Viking is studying promising candidates for both obesity and MASH in Phase II, but may need to prioritize one while partnering the other.

Choosing
Viking may face an appealing choice between a MASH or obesity focus • Source: Shutterstock

More from Strategy

More from Business